Exercise programs for depression in people with multiple sclerosis
Official title: Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Run by University of Illinois Chicago · NCT05051618 · Data updated 2026-11-12
This study is testing whether a structured exercise program or a stretching program can help people with multiple sclerosis and depression feel better and improve their health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 146 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | April 1, 2023 |
| Main results expected | October 31, 2026 |
| Study ends | October 31, 2026 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT05051618 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18 to 64 with a confirmed diagnosis of both multiple sclerosis and major depressive disorder.
✕Probably not a fit
Patients with significant ambulatory disability or those who are highly active may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research examines the effects of two different exercise training regimens on managing depression and improving health indicators in individuals with multiple sclerosis (MS) and major depressive disorder (MDD). The study will enroll 146 participants aged 18 to 64, comparing the efficacy of a structured exercise program (POWER-MS) against a stretching program (FLEX-MS). Participants will be required to complete various assessments and engage in exercise testing to evaluate the impact on their depression severity.
Why it matters
Potential benefit: If successful, this study could provide a non-pharmacological approach to effectively manage depression in patients with multiple sclerosis.
How similar studies have gone: Other studies have shown positive outcomes with exercise interventions for depression, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Physical confirmed diagnosis of Multiple Sclerosis (MS) * Diagnosis of Major Depressive Disorder (MDD) - see below (MINI) * English as primary language * Eligible age (between 18 and 64 years old) * Relapse and steroid free in past 30 days * Internet and email access * Willingness to complete the testing and questionnaires, wear the accelerometer, undergo randomization, and engage in exercise testing Exclusion Criteria * Godin Leisure Time Exercise Questionnaire (GLTEQ): Exclude if health contribution score of 14 units or more. This assessment is administered to confirm insufficient baseline physical activity (i.e., not meeting current PA guidelines) * Patient Determined Disease Steps (PDDS): Exclude if score above '2' (i.e., greater than mild ambulatory disability). This assessment is administered as the proposed intervention focuses on walking as main modality for exercise training. The scale asks the participant to describe their walking situation on a scale of 0 to 8; where lower scores indicate better walking ability. * Beck Depression Inventory-Fast Screen (BDI-FS): Exclude if a score less than '4'. The scale measures depression and those with a score of '4' or below likely have very mild depression resulting in floor effects and/or spontaneous remission. * Physical Activity Readiness Questionnaire (PAR-Q): Exclude if more than one yes/affirmative response on this 7-item self-report assessment. This assessment is administered to exclude those individuals who are at a moderate to high risk for contraindications of injury or possible death when undertaking strenuous or maximal exercise. This is a 7-item self-report tool where more than one yes/affirmative response indicates that an individual is not recommended to engage in physical activity within the capacity of this study. Those scoring more than one yes/affirmative response will be further advised to seek medical guidance before becoming more physically active. * Telephone Interview for Cognitive Status (TICS-M): Exclude if scores less than 18. This assessment is administered to ensure that all participants can adequately follow directions. The application of the TICS-M is to ensure that participants do not have severe cognitive impairment that might preclude the ability to adhere to the conditions, understand intervention content, and interact with behavior coaches. * MINI International Neuropsychiatric Interview (version 7.0.2) based on the Diagnostic and Statistical Manual of Mental Disorders V (DSM-V): Include those who meet the criteria for MDD, but exclude for other severe mental illness (obsessive-compulsive disorder, schizophrenia, bipolar or other psychotic disorders) as indicated by the MINI; these persons would require more intensive mental health treatment.
Where it's running
-
University of Illinois at Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Robert W Motl, PhD — University of Illinois Chicago
- Study coordinator: Robert W Motl, PhD
- Email: robmotl@uic.edu
- Phone: 205-975-1306
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
Dupilumab for Major Depressive Disorder
This study tests whether dupilumab can engage immune targets in adults with major depressive disorder to see if it can help with depressive symptoms.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.